Resolution of inflammation: state of the art, definitions and terms

被引:866
作者
Serhan, Charles N.
Brain, Sue D.
Buckley, Christopher D.
Gilroy, Derek W.
Haslett, Christopher
O'Neill, Luke A. J.
Perretti, Mauro
Rossi, Adriano G.
Wallace, John L.
机构
[1] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Oral Med Infect & Immun, Harvard Sch Dent Med, Boston, MA 02115 USA
[3] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England
[4] UCL, Ctr Clin Pharmacol & Therapeut, Div Med, London, England
[5] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland
[6] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland
[7] Queen Mary Univ London, William Harvey Res Inst, London, England
[8] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada
基金
英国医学研究理事会;
关键词
anti-inflammatories; leukocytes; lipid mediators; chemokines; cytokines;
D O I
10.1096/fj.06-7227rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27-28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti-inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter-regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation-associated diseases based on endogenous agonists of resolution.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 32 条
  • [1] NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
    Agostini, L
    Martinon, F
    Burns, K
    McDermott, MF
    Hawkins, PN
    Tschopp, J
    [J]. IMMUNITY, 2004, 20 (03) : 319 - 325
  • [2] Molecular circuits of resolution: Formation and actions of resolvins and protectins
    Bannenberg, GL
    Chiang, N
    Ariel, A
    Arita, M
    Tjonahen, E
    Gotlinger, KH
    Hong, S
    Serhan, CN
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (07) : 4345 - 4355
  • [3] Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
    Buckley, CD
    Pilling, D
    Lord, JM
    Akbar, AN
    Scheel-Toellner, D
    Salmon, M
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (04) : 199 - 204
  • [4] Cotran R., 1999, Robbins Pathologic Basis of Disease, V6th
  • [5] TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
    Creagh, Emma M.
    O'Neill, Luke A. J.
    [J]. TRENDS IN IMMUNOLOGY, 2006, 27 (08) : 352 - 357
  • [6] Going with the flow: methotrexate, adenosine, and blood flow
    Cronstein, BN
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) : 421 - 422
  • [7] Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis
    Damazo, Amilcar S.
    Yona, Simon
    Flower, Roderick J.
    Perretti, Mauro
    Oliani, Sonia M.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (07) : 4410 - 4418
  • [8] Targeting the stromal microenvironment in chronic inflammation
    Filer, Andrew
    Pitzalis, Costantino
    Buckley, Christopher D.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) : 393 - 400
  • [9] Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac
    Giles, KM
    Ross, K
    Rossi, AG
    Hotchin, NA
    Haslett, C
    Dransfield, I
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (02) : 976 - 986
  • [10] Inflammatory resolution: New opportunities for drug discovery
    Gilroy, DW
    Lawrence, T
    Perretti, M
    Rossi, AG
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) : 401 - 416